Colorectal cancer is a heterogenous disease that arises when mutations accumulate in intestinal epithelial cells and the body's immune system fails to recognize these mutant cells as pathogenic. In my lab, we study how factors that alter genetic stability in intestinal epithelial cells regulate anti-cancer immune responses by the mucosal immune system. This work will help to identify new therapeutic targets for the treatment of colorectal cancer.